188 related articles for article (PubMed ID: 15694690)
1. Pharmacological manipulation of ataxia-telangiectasia kinase activity as a treatment for Parkinson's disease.
Edwin Shackelford R; Manuszak RP; Heard SC; Link CJ; Wang S
Med Hypotheses; 2005; 64(4):736-41. PubMed ID: 15694690
[TBL] [Abstract][Full Text] [Related]
2. Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress.
Shackelford RE; Manuszak RP; Johnson CD; Hellrung DJ; Link CJ; Wang S
DNA Repair (Amst); 2004 Oct; 3(10):1263-72. PubMed ID: 15336622
[TBL] [Abstract][Full Text] [Related]
3. Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells.
Shackelford RE; Fu Y; Manuszak RP; Brooks TC; Sequeira AP; Wang S; Lowery-Nordberg M; Chen A
DNA Repair (Amst); 2006 Nov; 5(11):1327-36. PubMed ID: 16959548
[TBL] [Abstract][Full Text] [Related]
4. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
Youdim MB; Stephenson G; Ben Shachar D
Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
[TBL] [Abstract][Full Text] [Related]
5. The ZFHX3 (ATBF1) transcription factor induces PDGFRB, which activates ATM in the cytoplasm to protect cerebellar neurons from oxidative stress.
Kim TS; Kawaguchi M; Suzuki M; Jung CG; Asai K; Shibamoto Y; Lavin MF; Khanna KK; Miura Y
Dis Model Mech; 2010; 3(11-12):752-62. PubMed ID: 20876357
[TBL] [Abstract][Full Text] [Related]
6. The checkpoint kinase ATM protects against stress-induced elevation of cyclin D1 and potential cell death in neurons.
Hitomi M; Stacey DW
Cytometry A; 2010 Jun; 77(6):524-33. PubMed ID: 20506465
[TBL] [Abstract][Full Text] [Related]
7. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic manipulation of the ataxia-telangiectasia mutated gene product as an intervention in age-related disease.
Shackelford RE
Med Hypotheses; 2005; 65(2):363-9. PubMed ID: 15922113
[TBL] [Abstract][Full Text] [Related]
9. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
10. Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation.
Xue L; Yu D; Furusawa Y; Okayasu R; Tong J; Cao J; Fan S
Mutat Res; 2009 Nov; 670(1-2):15-23. PubMed ID: 19583974
[TBL] [Abstract][Full Text] [Related]
11. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle.
Biton S; Barzilai A; Shiloh Y
DNA Repair (Amst); 2008 Jul; 7(7):1028-38. PubMed ID: 18456574
[TBL] [Abstract][Full Text] [Related]
12. The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX.
Ye R; Goodarzi AA; Kurz EU; Saito S; Higashimoto Y; Lavin MF; Appella E; Anderson CW; Lees-Miller SP
DNA Repair (Amst); 2004 Mar; 3(3):235-44. PubMed ID: 15177039
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of ataxia telangiectasia mutated gene can increase intracellular reactive oxygen species levels and alter radiation-induced cell death pathways in human glioma cells.
Wang SC; Wu CC; Wei YY; Hong JH; Chiang CS
Int J Radiat Biol; 2011 Apr; 87(4):432-42. PubMed ID: 21204616
[TBL] [Abstract][Full Text] [Related]
14. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.
Bredemeyer AL; Sharma GG; Huang CY; Helmink BA; Walker LM; Khor KC; Nuskey B; Sullivan KE; Pandita TK; Bassing CH; Sleckman BP
Nature; 2006 Jul; 442(7101):466-70. PubMed ID: 16799570
[TBL] [Abstract][Full Text] [Related]
15. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
[TBL] [Abstract][Full Text] [Related]
16. Modeling ATM mutant proteins from missense changes confirms retained kinase activity.
Barone G; Groom A; Reiman A; Srinivasan V; Byrd PJ; Taylor AM
Hum Mutat; 2009 Aug; 30(8):1222-30. PubMed ID: 19431188
[TBL] [Abstract][Full Text] [Related]
17. The ATM-dependent DNA damage signaling pathway.
Kitagawa R; Kastan MB
Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
[TBL] [Abstract][Full Text] [Related]
18. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
19. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling.
Kim J; Wong PK
Stem Cells; 2009 Aug; 27(8):1987-98. PubMed ID: 19544430
[TBL] [Abstract][Full Text] [Related]
20. ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells.
Biton S; Gropp M; Itsykson P; Pereg Y; Mittelman L; Johe K; Reubinoff B; Shiloh Y
DNA Repair (Amst); 2007 Jan; 6(1):128-34. PubMed ID: 17178256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
